ADX10059 + ADX10059 Matching Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Gastroesophageal Reflux
Conditions
Gastroesophageal Reflux
Trial Timeline
Dec 1, 2008 → —
NCT ID
NCT00820079About ADX10059 + ADX10059 Matching Placebo
ADX10059 + ADX10059 Matching Placebo is a phase 2 stage product being developed by Addex Therapeutics for Gastroesophageal Reflux. The current trial status is completed. This product is registered under clinical trial identifier NCT00820079. Target conditions include Gastroesophageal Reflux.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00820079 | Phase 2 | Completed |
Competing Products
20 competing products in Gastroesophageal Reflux